Commonly Reported Adverse Events Associated With Pediatric Immunotherapy: A Systematic Review From the Children's Oncology Group
Janice S WithycombeAimee CarlsonCarly ColemanSharon Lynn LeslieMicah A SkeensHanna TseitlinElizabeth A DuffyPublished in: Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses (2020)
Immunotherapy is rapidly emerging as an effective therapy for pediatric cancers. Nurses need to be aware of the breadth of agent-specific, immunotherapy-related AEs to appropriately monitor and manage patients receiving these therapies. Additional work is needed to confidently profile immunotherapy-related AEs in pediatric oncology and to develop agent-specific educational materials for patients/families.